Spectral AI, Inc.

NasdaqCM MDAI

Spectral AI, Inc. Price to Sales Ratio (P/S) on February 06, 2025: 1.51

Spectral AI, Inc. Price to Sales Ratio (P/S) is 1.51 on February 06, 2025, a -26.23% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Spectral AI, Inc. 52-week high Price to Sales Ratio (P/S) is 2.83 on March 15, 2024, which is 87.13% above the current Price to Sales Ratio (P/S).
  • Spectral AI, Inc. 52-week low Price to Sales Ratio (P/S) is 0.72 on October 03, 2024, which is -52.76% below the current Price to Sales Ratio (P/S).
  • Spectral AI, Inc. average Price to Sales Ratio (P/S) for the last 52 weeks is 1.55.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
SV Wall Street
NasdaqCM: MDAI

Spectral AI, Inc.

CEO Mr. Wensheng Fan
IPO Date April 6, 2021
Location United States
Headquarters 2515 McKinney Avenue
Employees 78
Sector Healthcare
Industries
Biotechnology 3D Printing Artificial Intelligence (AI) Autonomous Driving Big Data Medical Instruments Robotics Telehealth
Description

Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.

StockViz Staff

February 8, 2025

Any question? Send us an email